Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Debt (2016 - 2025)

CV Sciences (CVSI) has disclosed Total Debt for 8 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Total Debt rose 143.57% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 143.57% year-over-year, with the annual reading at $1.6 million for FY2025, 143.57% up from the prior year.
  • Total Debt hit $1.6 million in Q4 2025 for CV Sciences, up from $955000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.6 million in Q4 2025 to a low of $363000.0 in Q1 2021.
  • Historically, Total Debt has averaged $1.0 million across 3 years, with a median of $1.1 million in 2025.
  • Biggest YoY gain for Total Debt was 143.57% in 2025; the steepest drop was 143.57% in 2025.
  • Year by year, Total Debt stood at $363000.0 in 2021, then surged by 86.5% to $677000.0 in 2024, then soared by 143.57% to $1.6 million in 2025.
  • Business Quant data shows Total Debt for CVSI at $1.6 million in Q4 2025, $955000.0 in Q3 2025, and $1.2 million in Q2 2025.